Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cells

References

• Wcisło-Dziadecka D, Grabarek B, Zmarzły N, et al. Influence of adalimumab on the expression profile of genes associated with the histaminergic system in the skin fibroblasts in vitro. Biomed Res Int. 2018Jan2;2018:1582173. PMID: 29487864; PMCID: PMC5816894.
   PubMed Web of Science ®Google Scholar
• Li B, Zhu JN, Wang JJ. Histaminergic afferent system in the cerebellum: structure and function. CerebellumAtaxias. 2014Jun16;1:5. PMID: 26331029; PMCID: PMC4549136.
   Google Scholar
• Reich A, Adamski Z, Chodorowska G, et al. Psoriasis. diagnostic and therapeutic recommendations of the polish dermatological society. part 2. Dermatology Review/Przeglad Dermatologiczny. 2020;107(2):110–137.
   Google Scholar
• Szczerkowska-Dobosz A, and Nowicki R. Algorytm leczenia łuszczycy. ABC łuszczycy. Łuszczyca w pytaniach i odpowiedziach Poznań, Poland: Termedia Sp z o. o. 2016;155–162. 987-83-7988-122-2.
   Google Scholar
• Zhuang QX, Xu HT, Lu XJ, et al. Histamine excites striatal dopamine D1 and D2 receptor-expressing neurons via postsynaptic H1 and H2 receptors. Mol Neurobiol. 2018;55(10):8059–8070.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang Y, and Chen Z. Central histaminergic signaling, neural excitability, and epilepsy. British Journal of Pharmacology. 2020;179:3–22. https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bph.15692
   Web of Science ®Google Scholar
• Valizadegan F, Zarrindast M. Interaction between dorso-hyppocampal histaminergic and medio-septal opioidergic systems in anxiety behavior. Nova BiologicaReperta. 2017;4(2):189–200.
   Google Scholar
• Feldmann M, Williams RO, Paleolog E. What have we learnt from targeted anti-TNF therapy? Ann RheumDis. 2010Jan;69(Suppl 1):i97–99. PMID: 19995756.
   PubMedGoogle Scholar
• Benhadou F, Mintoff D, Del Marmol V. Psoriasis: keratinocytes or immune cells–which is the trigger? Dermatology. 2019;235(2):91–100.
   PubMed Web of Science ®Google Scholar
• Hugh JM, Weinberg JM. Update on the pathophysiology of psoriasis. Cutis. 2018;102(5S):6–12.
   PubMedGoogle Scholar
• Deng Y, Chang C, Lu Q. The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(3):377–389.
   PubMed Web of Science ®Google Scholar
• de Freire Cassia F, Cardoso JF, Porto LC, et al. Association of HLA alleles and HLA haplotypes with psoriasis, psoriatic arthritis and disease severity in a miscegenated population. Psoriasis: Targets and Ther. 2021;11:41.
   PubMedGoogle Scholar
• Stannard JN, Reed TJ, Myers E, et al. Lupus skin is primed for IL-6 inflammatory responses through a keratinocyte-mediated autocrine type I interferon loop. J Invest Dermatol. 2017;137(1):115–122.
   PubMed Web of Science ®Google Scholar
• Bunker EN, Wheeler GE, Chapnick DA, et al. Suppression of α-catenin and adherens junctions enhances epithelial cell proliferation and motility via TACE-mediated TGF-α autocrine/paracrine signaling. Mol Biol Cell. 2021;32(4):348–361.
   PubMed Web of Science ®Google Scholar
• Grabarek BO, Kasela T, Adwent I, et al. Evaluation of the influence of adalimumab on the expression profile of leptin-related genes and proteins in keratinocytes treated with lipopolysaccharide a. Int J Mol Sci. 2021;22(4):1595.
   PubMed Web of Science ®Google Scholar
• Grabarek BO, Dąbala M, and Kasela T, et al. Changes in the expression pattern of DUSP1-7 and miRNA regulating their expression in the keratinocytes treated with LPS and adalimumab. Curr Pharm Biotechnol. 2021;23(6):873–881. doi:10.2174/1389201022666210802102508.
   Web of Science ®Google Scholar
• Adwent I, Grabarek BO, and Kojs-Mrożkiewicz M, et al. The influence of adalimumab and cyclosporine a on the expression profile of the genes related to TGFβ signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A Mediators of Inflammation. Mediators of Inflammation. 2020;2020:1–11. https://www.hindawi.com/journals/mi/2020/3821279/.
   Web of Science ®Google Scholar
• Grabarek B, Schweizer M, and Adwent I, et al. Differences in expression of genes related to drug resistance and miRNAs regulating their expression in skin fibroblasts exposed to Adalimumab and cyclosporine A. Adv in Dermatol and Allergology/Postepy Dermatologii I Alergologii. 2020;36(1):249–255.
   Google Scholar
• Tsao MC, Walthall BJ, Ham RG. Clonal growth of normal human epidermal keratinocytes in a defined medium. J Cell Physiol. 1982;110(2):219–229.
   PubMed Web of Science ®Google Scholar
• Dalmau N, Andrieu-Abadie N, Tauler R, et al. Phenotypic and lipidomic characterization of primary human epidermal keratinocytes exposed to simulated solar UV radiation. J Dermatol Sci. 2018;92(1):97–105.
   PubMed Web of Science ®Google Scholar
• Colombo I, Sangiovanni E, Maggio R, et al. HaCaT cells as a reliable in vitro differentiation model to dissect the inflammatory/repair response of human keratinocytes. Mediators Inflamm. 2017;2017:1–12.
   Web of Science ®Google Scholar
• Deyrieux AF, Wilson VG. In vitro culture conditions to study keratinocyte differentiation using the HaCaT cell line. Cytotechnology. 2007;54(2):77–83.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Spanò F, Contatore M, et al. Immunogenicity of infliximab and Adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety? Expert Opin DrugSaf. 2016Jan;15(1):43–52. Epub 2015 Nov 11. PMID: 26559805.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Negrini S, Greco M, et al. Immunogenicity of infliximab and Adalimumab. Expert Opin DrugSaf. 2019May;18(5):343–345. Epub 2019 Apr 16. PMID: 30938213.
   PubMed Web of Science ®Google Scholar
• Feldmann M, Maini RN. Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us? J Immunol. 2010Jul15;185(2):791–794. PMID: 20601610.
   PubMed Web of Science ®Google Scholar
• Fujisaki Y, Yamauchi A, Shuto H, et al. Pharmacological characterization of cyclosporine A-induced kaolin intake in rats. PharmacolBiochemBehav. 2001Oct-Nov;70(2–3):267–271. PMID: 11701197.
   Google Scholar
• Zhang S, Cheng Z, Wang Y, et al. The risks of miRNA therapeutics: in a drug target perspective. Drug Des Devel Ther. 2021;15:721–733.
   PubMed Web of Science ®Google Scholar
• Bavelloni A, Ramazzotti G, Poli A, et al. MiRNA-210: a current overview. Anticancer Res. 2017;37(12):6511–6521.
   PubMed Web of Science ®Google Scholar
• Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23–38.
   PubMed Web of Science ®Google Scholar
• Dor Y, Cedar H. Principles of DNA methylation and their implications for biology and medicine. Lancet. 2018;392(10149):777–786.
   PubMed Web of Science ®Google Scholar
• Budak M, Ozkan U, Yildiz M. Identification of potential methylation regions of the Smad4 mRNA and determining primer sequences for MS-PCR with the ‘Methprimer’program. Int J Genet Genomics. 2019;7(3):55.
   Google Scholar
• Stolzenbach F, Valdivia S, Ojeda-Provoste P, et al. BBA-molecular basis of disease.
   Google Scholar
• Yin Y, Morgunova E, Jolma A, et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. 2017;356(6337).
   Web of Science ®Google Scholar
• Locke WJ, Guanzon D, Ma C, et al. DNA methylation cancer biomarkers: translation to the clinic. Front Genet. 2019;10:1150.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee Y, Lu X, et al. Polycomb-and methylation-independent roles of EZH2 as a transcription activator. Cell Rep. 2018;25(10):2808–2820.
   PubMed Web of Science ®Google Scholar
• McLaughlin K, Flyamer IM, Thomson JP, et al. DNA methylation directs polycomb-dependent 3D genome re-organization in naive pluripotency. Cell Rep. 2019;29(7):1974–1985.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam J, et al. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang X, Yuhao Chen and Xiaowei Wang. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–D131.
   PubMed Web of Science ®Google Scholar
• Triantafilou M, and Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002 June 01;23(6):301–304.
   PubMed Web of Science ®Google Scholar
• Mirnaghizadeh SV, Zendehdel M, Babapour V. Involvement of histaminergic and noradrenergic receptors in the oxytocin-induced food intake in neonatal meat-type chicks. Vet Res Commun. 2017;41(1):57–66.
   PubMed Web of Science ®Google Scholar
• Jochem J, Zwirska-Korczala K, Sowa P, et al. Interactions between the histaminergic and angiotensinergic systems in the central cardio-vascular regulation in rats. Inflamm Res. 2006;55(Suppl. 1):s69–S70.
   PubMedGoogle Scholar
• Mi H, Ebert D, Muruganujan A, et al. PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions, and extensive API. Nucleic Acids Res. 2021;49(D1):D394–D403.
   PubMed Web of Science ®Google Scholar
• Stark H. Histaminereceptors. Biotrend Rev. 2007;11:1–9.
   Google Scholar
• Zmarzły N, Hermyt E, and Kruszniewska-Rajs C, et al. Expression profile of EMT-related genes and miRNAs involved in signal transduction via the WntPathway and cadherins in endometrialcancer. Curr Pharm Biotechnol. 2021;22(12):1663–1671. doi:10.2174/1389201021666201218125900.
   PubMed Web of Science ®Google Scholar
• Fitzsimons C, Engel N, Policastro L, et al. BiochemicalPharmacol 2002. Biochemical Pharmacology. 2002;63:1785–1796.
   PubMedGoogle Scholar
• Yang CC, Hung YL, Li HJ, et al. Quercetin inhibits histamine-induced calcium influx in human keratinocyte via histamine H4 receptors. Int Immunopharmacol. 2021;96:107620.
   PubMed Web of Science ®Google Scholar
• Kępska M, and Futoma-Kołoch B. Test immunoenzymatyczny ELISA-zasada działania i optymalizacja reakcji. Laboratorium Medyczne. 2018;2:42–29. https://yadda.icm.edu.pl/baztech/element/bwmeta1.element.baztech-f5f3b1ea-9120-4009-b3f7-9ffaa7753fef.
   Google Scholar
• Beermann S, Seifert R, Neumann D. Commercially available antibodies against human and murine histamine H 4-receptor lack specificity. Naunyn-Schmiedeberg’s Arch Pharmacol. 2012;385(2):125–135.
   Google Scholar
• Glatzer F, Gschwandtner M, Ehling S, et al. Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor. J Allergy Clin Immunol. 2013;132(6):1358–1367.
   PubMed Web of Science ®Google Scholar
• Nakahara T, Kido‐Nakahara M, Ohno F, et al. The pruritogenic mediator endothelin‐1 shifts the dendritic cell–T‐cell response toward Th17/Th1 polarization. Allergy. 2018;73(2):511–515.
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Komine M, Karakawa M, et al. Histamine differentially regulates the production of Th1 and Th2 chemokines by keratinocytes through histamine H1 receptor. Cytokine. 2011;54(2):191–199.
   PubMed Web of Science ®Google Scholar
• Cannon KE, Chazot PL, Hann V, et al. Rice Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain. 2007;129:76–92.
   PubMed Web of Science ®Google Scholar
• Suwa E, Yamaura K, Sato S, et al. Increased expression of the histamine H4 receptor following differentiation and mediation of the H4 receptor on interleukin-8 mRNA expression in HaCaT keratinocytes. Exp Dermatol. 2014;23(2):138–140.
   PubMed Web of Science ®Google Scholar
• Simsekoglu MF, Kaleler I, Onal B, et al. Do urinary mast cell mediators predict immune response to BCG in patients with primary high‐grade non‐muscle invasive bladder cancer? Int J Clin Pract. 2021;75(5):e13959.
   PubMed Web of Science ®Google Scholar
• Naganuma F, Nakamura T, Yoshikawa T, et al. Histamine N-methyltransferase regulates aggression and the sleep-wake cycle. Sci Rep. 2017;7:15899.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Nakamura T, Yanai K. Histamine N-Methyltransferase in the brain. Int J Mol Sci. 2019;20(3):737.
   Web of Science ®Google Scholar
• Kacik J, Wawrzyniak A, Rakowska M, et al. Objawy pseudoalergii a zaburzenia metabolizmu histaminy. Pediatria i Medycyna Rodzinna. 2016;12(3):234–241.
   Google Scholar
• Szukalski B. Neurotoksyczność metaamfetaminy – morfologiczne i molekularne zmiany w mózgu. Farmacja Polska. 2009;65(9):655–663. https://ptfarm.pl/pub/File/Farmacja%20Polska/2009/9/11%20%20Neurobiologiczne%20podstawy.pdf.
   Google Scholar
• Ares – Santos S, Granado N, Espadas I, et al. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology. 2014;39(5):1066–1080.
   PubMed Web of Science ®Google Scholar
• Osadchiy V, Mayer EA, Gao K, et al. Analysis of brain networks and fecal metabolites reveals brain-gut alterations in premenopausal females with irritable bowel syndrome. Transl Psychiatry. 2020;10(1):1–8.
   PubMed Web of Science ®Google Scholar
• Grabarek B, Wcislo-Dziadecka D, Gola J, et al. Changes in the expression profile of Jak/Stat signaling pathway genes and miRNAs regulating their expression under the Adalimumab therapy. Curr Pharm Biotechnol. 2018;19(7):556–565.
   PubMed Web of Science ®Google Scholar
• Rajeev PD, Jain AK, Ramesh V. Current concepts in the pathogenesis of psoriasis. Indian J Dermatol. 2009;54(1):7–12.
   PubMedGoogle Scholar
• Zülal E, Erbagci AB, Köylüoglu O, et al. Serum adenosine deaminase activity in monitoring disease activity and response to therapy in severe psoriasis. Acta Medica (Hradec Králové). 2006;49(2):101–104.
   PubMedGoogle Scholar
• Sarianowska A, Krenke R, Dmowska – Sobstyl B, et al. Aktywność deaminazy adenozyny w gruźliczym I nowotworowym wysięku w opłucnej. Pneumonologia i Alergologia Polska. 2006;74:5–9.
   PubMedGoogle Scholar
• Khan SA, Agrawal S, Baral N, et al. Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients. Psoriasis: Targets and Ther. 2018;8:59–63.
   PubMed Web of Science ®Google Scholar
• Yildirim FE, Karaduman A, Pinar A, et al. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy. Int J Dermatol. 2011;50(8):948–955.
   PubMed Web of Science ®Google Scholar
• Nigam R, El-Nour H, Amatya B, et al. GABA and GABA A receptor expression on immune cells in psoriasis: a pathophysiological role. Arch Dermatol Res. 2010;302(7):507–515.
   PubMed Web of Science ®Google Scholar
• Fontana G, See E, Pandit A. Current trends in biologics delivery to restore intervertebral disc anabolism. Adv Drug Deliv Rev. 2015;84:146–158.
   PubMed Web of Science ®Google Scholar
• Shi S, Wang C, Acton AJ, et al. Role of Sox9 in growth factor regulation of articular chondrocytes. J Cell Biochem. 2015;116:391–1400.
   Web of Science ®Google Scholar
• Li Y, Pan D, Liu S, et al. Identification of circ-FAM169A sponges miR-583 involved in the regulation of intervertebral disc degeneration. J Orthop Translat. 2021;26:121–131.
   PubMed Web of Science ®Google Scholar
• Chen MH, Chen HA, Chen WS, et al. Upregulation of BMP-2 expression in peripheral blood mononuclear cells by proinflammatory cytokines and radiographic progression in ankylosing spondylitis. Mod Rheumatol. 2015;25(6):913–918.
   PubMed Web of Science ®Google Scholar
• Joo YB, Bang SY, and Kim TH, et al.Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis. PLoS One. 2014; 9(8):1–7. article e104966
   Web of Science ®Google Scholar
• Li Z, Chen J. miR‑583 inhibits the proliferation and invasion of prostate cancer cells by targeting JAK1. Mol Med Rep. 2021;23(3):1.
   PubMed Web of Science ®Google Scholar
• Farr R, Rootes C, Rowntree L, et al. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLOS Pathogens. 2021;17:e1009759.
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE. 2007;2:e610.
   PubMed Web of Science ®Google Scholar
• Raaby L, Langkilde A, Kjellerup RB, et al. Changes in mRNA expression precede changes in micro RNA expression in lesional psoriatic skin during treatment with Adalimumab. Br J Dermatol. 2015;173(2):436–447.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen C, Yan X, et al. The role of miR-382-5p in glioma cell proliferation, migration, and invasion. Onco Targets Ther. 2019;12:4993.
   PubMedGoogle Scholar
• Seok JK, Lee SH, Kim MJ, et al. MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res. 2014;42(12):8062–8072.
   PubMed Web of Science ®Google Scholar
• Biniecka M, Kennedy A, Ng CT, et al. Successful tumor necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res Ther. 2011;13(4):1–9.
   Web of Science ®Google Scholar
• Clayton SA, MacDonald L, Kurowska-Stolarska M, et al. Mitochondria as key players in the pathogenesis and treatment of rheumatoid arthritis. Front Immunol. 2021;12:1488.
   Web of Science ®Google Scholar